Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B: Focus on bladder cancer. Cancer Cell. 2004, 6: 111-116. 10.1016/j.ccr.2004.08.002.
Article
CAS
PubMed
Google Scholar
Amling CL: Diagnosis and management of superficial bladder cancer. Curr Probl Cancer. 2001, 25: 219-278.
Article
CAS
PubMed
Google Scholar
Abogunrin F, O'Kane HF, Ruddock MW, Stevenson M, Reid CN, O'Sullivan JM, Anderson NH, O'Rourke D, Duggan B, Lamont JV, Boyd RE, Hamilton P, Nambirajan T, Williamson KE: The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria. Cancer. 2012, 118: 2641-2650. 10.1002/cncr.26544.
Article
CAS
PubMed
Google Scholar
Esmon CT: The regulation of natural anticoagulant pathways. Science. 1987, 235: 1348-1352. 10.1126/science.3029867.
Article
CAS
PubMed
Google Scholar
Kao YC, Wu LW, Shi CS, Chu CH, Huang CW, Kuo CP, Sheu HM, Shi GY, Wu HL: Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition. Mol Cell Biol. 2010, 30: 4767-4785. 10.1128/MCB.01021-09.
Article
CAS
PubMed
PubMed Central
Google Scholar
ten Cate H, Falanga A: Overview of the postulated mechanisms linking cancer and thrombosis. Pathophysiol Haemost Thromb. 2008, 36: 122-130.
Article
PubMed
Google Scholar
Horowitz NA, Palumbo JS: Mechanisms coupling thrombomodulin to tumor dissemination. Thromb Res. 2012, 129 (Suppl 1): S119-S121.
Article
CAS
PubMed
Google Scholar
Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Böhrer H, Nakagawa M, Graeff H, Martin E, Stern DM, Rosenberg RD, Ziegler R, Nawroth PP: Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest. 1998, 101: 1301-1309. 10.1172/JCI925.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koutsi A, Papapanagiotou A, Papavassiliou AG: Thrombomodulin: from haemostasis to inflammation and tumourigenesis. Int J Biochem Cell Biol. 2008, 40: 1669-1673. 10.1016/j.biocel.2007.06.024.
Article
CAS
PubMed
Google Scholar
Ogawa H, Yonezawa S, Maruyama I, Matsushita Y, Tezuka Y, Toyoyama H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Sato E: Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett. 2000, 149: 95-103. 10.1016/S0304-3835(99)00348-1.
Article
CAS
PubMed
Google Scholar
Hanly AM, Redmond M, Winter DC, Brophy S, Deasy JM, Bouchier-Hayes DJ, Kay EW: Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer. 2006, 94: 1320-1325. 10.1038/sj.bjc.6603098.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hanly AM, Hayanga A, Winter DC, Bouchier-Hayes DJ: Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol. 2005, 31: 217-220. 10.1016/j.ejso.2004.11.017.
Article
CAS
PubMed
Google Scholar
Coussens LM, Werb Z: Inflammation and cancer. Nature. 2002, 420: 860-867. 10.1038/nature01322.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gonda TA, Tu S, Wang TC: Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle. 2009, 8: 2005-2013. 10.4161/cc.8.13.8985.
Article
CAS
PubMed
Google Scholar
Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y: Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004, 202: 275-293. 10.1111/j.0105-2896.2004.00199.x.
Article
CAS
PubMed
Google Scholar
Zhu Z, Shen Z, Xu C: Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm. 2012, 2012: 528690-doi: 10.1155/2012/528690
Article
PubMed
PubMed Central
Google Scholar
Ordonez NG: Thrombomodulin expression in transitional cell carcinoma. Am J Clin Pathol. 1998, 110: 385-390.
Article
CAS
PubMed
Google Scholar
Ordonez NG: Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology. 1997, 31: 517-524. 10.1046/j.1365-2559.1997.3040892.x.
Article
CAS
PubMed
Google Scholar
Weiler H, Lindner V, Kerlin B, Isermann BH, Hendrickson SB, Cooley BC, Meh DA, Mosesson MW, Shworak NW, Post MJ, Conway EM, Ulfman LH, von Andrian UH, Weitz JI: Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol. 2001, 21: 1531-1537. 10.1161/hq0901.094496.
Article
CAS
PubMed
Google Scholar
Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S: Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int. 2002, 61: 490-501. 10.1046/j.1523-1755.2002.00160.x.
Article
CAS
PubMed
Google Scholar
Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, Gardner K, Rade JJ: Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 2005, 105: 3910-3917. 10.1182/blood-2004-03-0928.
Article
CAS
PubMed
Google Scholar
Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T: Identification of silencing of nine genes in human gastric cancers. Cancer Res. 2002, 62: 6645-6650.
PubMed
Google Scholar
Wu CT, Wu CF, Lu CH, Lin CC, Chen WC, Lin PY, Chen MF: Expression and function role of DNA methyltransferase 1 in human bladder cancer. Cancer. 2011, 117: 5221-5233. 10.1002/cncr.26150.
Article
CAS
PubMed
Google Scholar
Chen MF, Lin PY, Wu CF, Chen WC, Wu CT: IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One. 2013, 8 (4): e61901-10.1371/journal.pone.0061901.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994, 12: 141-179. 10.1146/annurev.iy.12.040194.001041.
Article
CAS
PubMed
Google Scholar
Lin Y, Bai L, Chen W, Xu S: The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 2010, 14: 45-55. 10.1517/14728220903431069.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levidou G, Saetta AA, Korkolopoulou P, Papanastasiou P, Gioti K, Pavlopoulos P, Diamantopoulou K, Thomas-Tsagli E, Xiromeritis K, Patsouris E: Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder. Virchows Arch. 2008, 452: 295-304. 10.1007/s00428-007-0560-y.
Article
CAS
PubMed
Google Scholar
Rothwarf DM, Karin M: The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE. 1999, 1999 (5): RE1-
CAS
PubMed
Google Scholar
Wu CS, Chen MF, Lee IL, Tung SY: Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. J Clin Gastroenterol. 2007, 41: 894-900. 10.1097/MCG.0b013e31804c707c.
Article
CAS
PubMed
Google Scholar
Chen MF, Lu MS, Chen PT, Chen WC, Lin PY, Lee KD: Role of interleukin 1 beta in esophageal squamous cell carcinoma. J Mol Med (Berl). 2012, 90: 89-100. 10.1007/s00109-011-0809-4.
Article
CAS
Google Scholar
Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC: Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res. 2007, 13: 1685-1694. 10.1158/1078-0432.CCR-06-2330.
Article
CAS
PubMed
Google Scholar
McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, Siefker-Radtke A, Dinney C: Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 2009, 28: 335-344. 10.1007/s10555-009-9194-7.
Article
CAS
PubMed
Google Scholar
Honn KV, Tang DG: Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev. 1992, 11: 353-375. 10.1007/BF01307187.
Article
CAS
PubMed
Google Scholar
Becker KF, Rosivatz E, Blechschmidt K, Kremmer E, Sarbia M, Höfler H: Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs. 2007, 185: 204-212. 10.1159/000101321.
Article
CAS
PubMed
Google Scholar
Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000, 2: 76-83. 10.1038/35000025.
Article
CAS
PubMed
Google Scholar
Nakanishi R, Oka N, Nakatsuji H, Koizumi T, Sakaki M, Takahashi M, Fukumori T, Kanayama HO: Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer. Urol Int. 2009, 83: 98-106. 10.1159/000224877.
Article
CAS
PubMed
Google Scholar
Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M, Dall'Oglio MF: Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urol. 2012, 12: 18-10.1186/1471-2490-12-18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma S, Sharma MC, Sarkar C: Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005, 46: 481-489. 10.1111/j.1365-2559.2005.02142.x.
Article
CAS
PubMed
Google Scholar
Horowitz NA, Blevins EA, Miller WM, Perry AR, Talmage KE, Mullins ES, Flick MJ, Queiroz KC, Shi K, Spek CA, Conway EM, Monia BP, Weiler H, Degen JL, Palumbo JS: Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood. 2011, 118: 2889-2895. 10.1182/blood-2011-03-341222.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nocchi L, Tomasetti M, Amati M, Neuzil J, Santarelli L, Saccucci F: Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism. J Biol Chem. 2011, 286: 19478-19488. 10.1074/jbc.M110.217331.
Article
CAS
PubMed
PubMed Central
Google Scholar
Menschikowski M, Hagelgans A, Tiebel O, Vogel M, Eisenhofer G, Siegert G: Regulation of thrombomodulin expression in prostate cancer cells. Cancer Lett. 2012, 322: 177-184. 10.1016/j.canlet.2012.03.001.
Article
CAS
PubMed
Google Scholar
Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB: Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A. 1996, 93: 9090-9095. 10.1073/pnas.93.17.9090.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K: Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 2011, 308: 43-53. 10.1016/j.canlet.2011.04.012.
Article
CAS
PubMed
PubMed Central
Google Scholar